# ID3
## History
ID3 was first reported as mutated in BL in 2012 by Richter et al.<sup>1</sup> The existence of mutations in DLBCL were described in 2012 by Schmitz et al<sup>2</sup> and later in MZL by Spina et al.<sup>3</sup>
 
## Relevance tier by entity

|Entity|Tier|Description                              |
|:------:|:----:|-----------------------------------------|
|![BL](images/icons/BL_tier1.png)    |1 | high-confidence BL gene                  |
|![MZL](images/icons/MZL_tier1.png) |1 | high-confidence MZL gene |
|![DLBCL](images/icons/DLBCL_tier2.png) |2 | Although recurrent, the relevance of mutations in DLBCL is tenuous |

## Mutation incidence in large patient cohorts (GAMBL reanalysis)

|Entity|source               |frequency (%)|
|:------:|:---------------------:|:-------------:|
|BL    |GAMBL genomes+capture|45.50        |
|BL    |Thomas cohort        |47.00        |
|BL    |Panea cohort         |31.70        |
|DLBCL |GAMBL genomes        | 1.53        |
|DLBCL |Schmitz cohort       | 4.68        |
|DLBCL |Reddy cohort         | 3.50        |
|DLBCL |Chapuy cohort        | 0.85        |
|FL    |GAMBL genomes        | 0.92        |

## Mutation pattern and selective pressure estimates

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
|BL    |Yes |Yes                  |42.419          |439.808         |
|DLBCL |Yes |Yes                  | 0.000          | 30.520         |
|FL    |Yes |No                   | 3.497          |  0.000         |

## aSHM regions

|chr_name|hg19_start|hg19_end|region                                                                                   |regulatory_comment|
|:--------:|:----------:|:--------:|:-----------------------------------------------------------------------------------------:|:------------------:|
|chr1    |23885584  |23885835|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr1%3A23885584%2D23885835)|NA                |

View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/ID3_protein.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/ID3_protein_hg38.html)

![image](images/proteinpaint/ID3_NM_002167.svg)

View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/ID3.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/ID3_hg38.html)

![image](images/proteinpaint/ID3.svg)
## ID3 Expression
![image](images/gene_expression/ID3_by_pathology.svg)

## References
1.  *Richter J, Schlesner M, Hoffmann S, Kreuz M, Leich E, Burkhardt B, Rosolowski M, Ammerpohl O, Wagener R, Bernhart SH, Lenze D, Szczepanowski M, Paulsen M, Lipinski S, Russell RB, Adam-Klages S, Apic G, Claviez A, Hasenclever D, Hovestadt V, Hornig N, Korbel JO, Kube D, Langenberger D, Lawerenz C, Lisfeld J, Meyer K, Picelli S, Pischimarov J, Radlwimmer B, Rausch T, Rohde M, Schilhabel M, Scholtysik R, Spang R, Trautmann H, Zenz T, Borkhardt A, Drexler HG, Möller P, MacLeod RAF, Pott C, Schreiber S, Trümper L, Loeffler M, Stadler PF, Lichter P, Eils R, Küppers R, Hummel M, Klapper W, Rosenstiel P, Rosenwald A, Brors B, Siebert R, ICGC MMML-Seq Project. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet. 2012 Dec;44(12):1316–1320. PMID: 23143595*
2. *Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, Müller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Ogwang MD, Reynolds SJ, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pittaluga S, Wilson W, Waldmann TA, Rowe M, Mbulaiteye SM, Rickinson AB, Staudt LM. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012 Oct 4;490(7418):116–120. PMCID: PMC3609867*
3. *Spina V, Khiabanian H, Messina M, Monti S, Cascione L, Bruscaggin A, Spaccarotella E, Holmes AB, Arcaini L, Lucioni M, Tabbò F, Zairis S, Diop F, Cerri M, Chiaretti S, Marasca R, Ponzoni M, Deaglio S, Ramponi A, Tiacci E, Pasqualucci L, Paulli M, Falini B, Inghirami G, Bertoni F, Foà R, Rabadan R, Gaidano G, Rossi D. The genetics of nodal marginal zone lymphoma. Blood. 2016 Sep 8;128(10):1362–1373.*

<!-- ORIGIN: 22885699 -->
<!-- BL: richterRecurrentMutationID32012a -->
<!-- DLBCL: schmitzBurkittLymphomaPathogenesis2012 -->
<!-- MZL: spinaGeneticsNodalMarginal2016b -->
